PMA supplement
P030027 S002: CERAMIC TRANSCEND ARTICULATION SYSTEM
FDA PMA supplement · Real-Time Process · Microport Orthopedics, Inc.
Key facts
| Original PMA | P030027 |
|---|---|
| Supplement number | S002 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | CERAMIC TRANSCEND ARTICULATION SYSTEM |
| Generic name | Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented |
| Applicant | Microport Orthopedics, Inc. |
| Product code | MRA |
| Received date | Mar 8, 2006 |
| Decision date | Jun 23, 2006 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: